Transitional cell carcinoma of the ovary.
Yazigi
R
R
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Clinica Las Condes, Chile. ryazigi@clinicalascondes.cl
Sahid
S
S
Gutiérrez
J
J
Rodríguez
T
T
Contreras
L
L
D015746:Abdominal Pain / Q000175:diagnosis / Q000209:etiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001707:Biopsy, Needle; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology*; D002945:Cisplatin / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D035583:Rare Diseases; D018570:Risk Assessment; D016896:Treatment Outcome
D002945:Cisplatin; D008727:Methotrexate